BIOMAT Database Logo BIOMAT Database Logo

Antinuclear antibodies following hydralazine toxicity. 1967

J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine

Related Publications

J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
Hydralazine, antinuclear antibodies, and the lupus syndrome.
March 1982, British medical journal (Clinical research ed.),
J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
Hydralazine-induced antinuclear antibodies in beagle dogs.
March 1981, Toxicology and applied pharmacology,
J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
Hydralazine antinuclear antibodies and the lupus syndrome.
June 1982, British medical journal (Clinical research ed.),
J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
[Procainamide- and hydralazine-induced antinuclear antibodies in Japanese].
May 1987, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
Overlapping Syndromes: Drug-Induced Vasculitis From Hydralazine With Positive Antinuclear Antibodies.
January 2023, Clinical medicine insights. Case reports,
J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
[Acute immunologic hydralazine reaction. Clinical and serological changes after hydralazine administration to a patient with circulating antinuclear antibodies].
January 1972, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
[Antinuclear antibodies].
January 2010, Reumatologia clinica,
J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
Antinuclear antibodies.
May 1992, Rheumatic diseases clinics of North America,
J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
Antinuclear antibodies.
January 1975, Scandinavian journal of rheumatology. Supplement,
J J Condemi, and D Moore-Jones, and J H Vaughan, and H M Perry
Antinuclear antibodies.
January 1981, International journal of dermatology,
Copied contents to your clipboard!